Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9P4E

Crystal Structure of Engineered glutamine binding protein and a Gd-DOTA ligand - no GLN bound

これはPDB形式変換不可エントリーです。
9P4E の概要
エントリーDOI10.2210/pdb9p4e/pdb
関連するPDBエントリー9p4d
分子名称Amino acid ABC transporter substrate-binding protein, SULFATE ION, ACETATE ION, ... (8 entities in total)
機能のキーワードamino acid abc transporter, substrate binding protein, metal binding protein
由来する生物種Escherichia coli
タンパク質・核酸の鎖数1
化学式量合計26922.30
構造登録者
Bruchs, A.T.,Wilson, C.A.,Boggs, D.G.,Fatima, S.,Bridwell-Rabb, J.,Olshansky, L. (登録日: 2025-06-16, 公開日: 2026-01-14)
主引用文献Wilson, C.A.,Bruchs, A.T.,Fatima, S.,Boggs, D.G.,Bridwell-Rabb, J.,Olshansky, L.
Development of a glutamine-responsive MRI contrast agent.
Chem Sci, 2025
Cited by
PubMed Abstract: Magnetic resonance imaging (MRI) is widely used to visualize disease, and image quality can be improved through use of MRI contrast agents. Currently available agents produce a signal based solely on spatial distribution, but modern metabolic profiling has uncovered a variety of biomarkers for disease. For example, tumors greatly increase their uptake and catabolism of glutamine (Gln), leading to modified local concentration. Our laboratory previously developed a switchable artificial metalloprotein (swArM) platform in which Gln-binding causes a protein conformational change that modifies the physicochemical environment of an installed metallocofactor. Installing MRI-active metallocofactors within swArMs, we present a proof-of-concept approch toward the development of an analyte-responsive MRI contrast agent. To develop these swArMs, we tested several MRI-active metals (Gd, Dy), chelating ligands (DOTA, DTPA, NOTA), and attachment sites, as well as the impacts of peripheral mutations on the Gln-responsive signal. In each case, metal content was analytically defined, and Gln-binding affinity was determined by isothermal titration calorimetry. Circular dichroism was used to verify that our swArMs could still undergo the conformational change. X-ray diffraction structures of the and swArMs further revealed that the metallocofactor is significantly solvent-exposed in both conformations, but exhibits additional interactions with the protein in the state coinciding with the observed increase in relaxivity of ∼60% upon Gln-binding.
PubMed: 41395538
DOI: 10.1039/d5sc05987a
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.02 Å)
構造検証レポート
Validation report summary of 9p4e
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon